Skip to content

Clinical trials

Recruiting Phase 1/2 Lymphoma, T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 1/2 Status: Recruiting Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20211
20222
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital2
BioInvent International AB1
City of Hope Medical Center1
Dizal Pharmaceuticals1
Essen Biotech1
Fred Hutchinson Cancer Center1
Novartis Pharmaceuticals1
Peking University People's Hospital1
Step Pharma, SAS1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell12
Lymphoma, T-Cell, Cutaneous3
Lymphoma, B-Cell2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Endometrial Neoplasms1
Immune System Diseases1
Immunoproliferative Disorders1
Leukemia, Prolymphocytic, T-Cell1
Leukemia, T-Cell1
Lymphatic Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.